ACM
KYMR icon

Aquatic Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Aquatic Capital Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,690
Closed -$209K – 1614
2025
Q4 		$209K Sell
2,690
-12,663
-82% -$855K 0.01% 984
2025
Q3 		$869K Sell
15,353
-1,658
-10% -$74.8K 0.02% 717
2025
Q2 		$742K Buy
+17,011
New +$586K 0.02% 725
2025
Q1 		– Sell
-19,431
Closed -$782K – 1462
2024
Q4 		$782K Buy
+19,431
New +$878K 0.02% 610
2024
Q3 		– Sell
-13,900
Closed -$415K – 1365
2024
Q2 		$415K Buy
13,900
+2,100
+18% +$72.7K 0.02% 586
2024
Q1 		$474K Buy
+11,800
New +$422K 0.02% 560
2023
Q4 		– Sell
-12,200
Closed -$170K – 1491
2023
Q3 		$170K Buy
12,200
+8,000
+190% +$161K 0.01% 714
2023
Q2 		$97K Buy
4,200
+2,800
+200% +$80.2K 0.01% 857
2023
Q1 		$41K Sell
1,400
-9,100
-87% -$293K ﹤0.01% 924
2022
Q4 		$262K Buy
+10,500
New +$280K 0.02% 682

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Aquatic Capital Management's KYMR Position: Q1 2026 in Review

Aquatic Capital Management sold out of Kymera Therapeutics (KYMR) in Q1 2026, closing a stake of 2,690 shares — an estimated $209K sold.

Aquatic Capital Management first reported a position in KYMR in Q4 2022 and held it in 10 quarters. The position peaked at $869K in Q3 2025. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Aquatic Capital Management reported no remaining Kymera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 2,690 Kymera Therapeutics shares in Q1 2026, an estimated $209K.
  • Aquatic Capital Management first reported a position in Kymera Therapeutics in Q4 2022 and held it in 10 quarters.
  • Aquatic Capital Management's Kymera Therapeutics position peaked at $869K in Q3 2025.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.